Autophagy Activation by Resveratrol Reduces Severity of Experimental Rheumatoid Arthritis

Scope Previous work reported that dietary supplementation with resveratrol lowers synovial hyperplasia, inflammatory and oxidative damage in an antigen-induced arthritis (AIA) model. Here, it is investigated whether resveratrol can regulate the abnormal synovial proliferation by inducing autophagy and controlling the associated inflammatory response. Methods and results Animals treated with resveratrol 8 weeks before AIA induction show the highest significant signal for microtubule-associated protein 1 light chain 3 by confocal microscopy. Besides, resveratrol significantly reduces p62 expression, but it does not increase the signal of beclin-1. Also, active caspase-3 expression, as well as poly(ADP-ribose) polymerase, is upregulated in the AIA group, and is significantly reduced in resveratrol-treated AIA group. Resveratrol also mitigates angiopoietin-1 and vascular endothelial growth factor signals. Finally, resveratrol significantly reduces the serum levels of IL-1 beta, C reactive protein, and prostaglandin E2, as well as nuclear factor kappa B synovial tissue expression, which shows a significant correlation with p62 expression. Conclusion Dietary supplementation with resveratrol induces the noncanonical autophagy pathway and limits the cross-talk with inflammation, which in consequence modulates the synovial hyperplasia. Preventive strategies that incorporate dietary intervention with resveratrol may offer a potential therapeutic alternative to drugs to influence the risk of rheumatoid arthritis and influence its course.

Automated summary

The study shows that dietary supplementation with resveratrol induces the noncanonical autophagy pathway and limits its interaction with inflammation, leading to modulation of synovial hyperplasia. This dietary intervention with resveratrol may offer a potential therapeutic alternative to influence the risk and course of rheumatoid arthritis.